Anuncia Medical key facts
as of Oct 2026- Developer of a ventricular system designed for the treatment of hydrocephalus.
- Anuncia Medical is valued at approximately $26.0M as of Oct 2026, set at its later-stage round, Feb 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $22.6M across 3 recorded rounds; the latest was Early Stage VC ($13.9M) in Aug 2024.
- Notable investors include Flinn Foundation, Pimlico Pond Investments, U.S. Boston Growth Capital, Alliance of Angels, Ariel Savannah Angel Partners — 11 tracked in total.
- Anuncia Medical has filed 9 Form Ds with the SEC since 2021, most recently Nov 2025 ($13.9M sold to 87 investors).
- Status: Privately Held (backing).
Valued at $26.0M at its later-stage round, Feb 2025. Nothing has traded since.
- ·The complete investor list: 11 names
- ·Watch Anuncia Medical: the Monday email on marks, rounds and moves
Anuncia Medical funding rounds
3 roundsWho backs Anuncia Medical
11+Membership and data by Private Market View
Anuncia Medical valuation
Anuncia Medical was valued at $26 million at its later-stage round in Feb 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Anuncia Medical raised?
Anuncia Medical has raised $22.6 million across 3 recorded rounds since 2021. The largest was a $427,500 seed round in Oct 2021; the most recent was a $13.9 million early-stage round in Aug 2024.
Anuncia Medical has filed 9 Form Ds with the SEC since 2021, most recently in Nov 2025 ($13.9 million sold to 87 investors).
Anuncia Medical investors
11 investors are on record for Anuncia Medical, including Flinn Foundation, Pimlico Pond Investments, U.S. Boston Growth Capital and Alliance of Angels. The early-stage round in Aug 2024 drew 87 investors.
About Anuncia Medical
Developer of a ventricular system designed for the treatment of hydrocephalus. The company's neurotherapeutic device helps in cerebrospinal fluid management and neurocritical care of repeat revision brain surgeries and prevents complications of non-flowing shunts, enabling healthcare providers to treat the brain damage conditions of their patients.
- Sector
- Healthcare
- HQ
- Scottsdale, AZ, United States
- Founded
- 2018
- Employees
- 10
- Website
- anunciamedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.